Bratisl Lek Listy. 2023;124(6):421-426. doi: 10.4149/BLL_2023_064.
This work was aimed at analyzing in-hospital, 30-day and 1-year mortality rates, impact of selected cardiovascular factors on mortality of patients with ST-segment elevation myocardial infarction (STEMI) manifested on electrocardiogram (ECG) and treated by the percutaneous coronary intervention (PCI) at our cardiac center, comparing the subgroup of non-shock (survivors and deceased) patients after STEMI and evaluating how these patients differ from each other.
In total, 270 patients with STEMI manifested on ECG and treated by PCI were enrolled between April 1, 2018, and March 31, 2019, at our cardiologic center. Our study sought to determine the risk of death after acute myocardial infarction with carefully selected factors and parameters such as the presence of cardiogenic shock, ischemic time, left ventricular ejection fraction (LVEF), post‑PCI TIMI (thrombolysis in myocardial infarction) flow and serum levels of cardio‑specific markers, namely troponin T, creatine kinase and N-terminal pro-brain natriuretic peptide (NT-proBNP). Further evaluation included in-hospital, 30-day and 1-year mortality rates in shock and non-shock patients and determination of factors that influence the survival separately in each subgroup. The follow-up was carried out for 12 months after the myocardial infarction in form of outpatient examinations. After 12 months of follow-up, the collected data were statistically evaluated.
Shock and non-shock patients differed in mortality and several other parameters including NT-proBNP values, ischemic time, TIMI flow defect and LVEF. In all outcomes (in-hospital, 30-day and 1-year mortality rates) the shock patients did worse than non-shock patients (p < 0.001). In addition, age, gender, LVEF, NT-proBNP and post‑PCI TIMI flow less than 3 were found to be important factors influencing the overall survival. In shock patients, the survival was associated with age, LVEF and TIMI flow, while in non-shock patients, the factors predicting survival were age, LVEF, level of NT-proBNP and troponin levels.
Shock patients differed in terms of mortality in post-PCI TIMI flow, while non-shock patients varied in troponin and NT-proBNP levels. Despite early intervention, certain risk factors might affect the clinical outcome and prognosis of patients with STEMI treated by PCI (Tab. 5, Fig. 1, Ref. 30). Text in PDF www.elis.sk Keywords: myocardial infarction, primary coronary intervention, shock, mortality, cardio‑specific markers.
本研究旨在分析我院心血管中心经皮冠状动脉介入治疗(PCI)的心电图(ECG)表现为 ST 段抬高型心肌梗死(STEMI)患者的住院期间、30 天和 1 年死亡率,以及选择的心血管因素对死亡率的影响,并比较 STEMI 后非休克(存活和死亡)患者的亚组,评估这些患者之间的差异。
2018 年 4 月 1 日至 2019 年 3 月 31 日期间,我院心内科共收治 270 例 STEMI 患者行 PCI 治疗。本研究旨在通过仔细选择的因素和参数(如心源性休克、缺血时间、左心室射血分数(LVEF)、PCI 后 TIMI(心肌梗死溶栓)血流和血清心特标志物肌钙蛋白 T、肌酸激酶和 N 端脑钠肽前体(NT-proBNP)水平)确定急性心肌梗死后死亡的风险。进一步评估包括休克和非休克患者的住院期间、30 天和 1 年死亡率,并确定在每个亚组中分别影响生存的因素。通过门诊检查对心肌梗死后 12 个月进行随访。12 个月随访后,对收集的数据进行统计学评估。
休克和非休克患者的死亡率和其他一些参数(包括 NT-proBNP 值、缺血时间、TIMI 血流缺陷和 LVEF)存在差异。在所有结局(住院期间、30 天和 1 年死亡率)中,休克患者的预后均差于非休克患者(p<0.001)。此外,年龄、性别、LVEF、NT-proBNP 和 PCI 后 TIMI 血流<3 被认为是影响总生存率的重要因素。在休克患者中,生存率与年龄、LVEF 和 TIMI 血流相关,而非休克患者中,预测生存率的因素为年龄、LVEF、NT-proBNP 水平和肌钙蛋白水平。
休克患者的 TIMI 血流预后不同,而非休克患者的肌钙蛋白和 NT-proBNP 水平不同。尽管进行了早期干预,但某些危险因素可能会影响 STEMI 患者经 PCI 治疗的临床结局和预后(表 5、图 1、参考文献 30)。